Efficacy News and Research

RSS
Researchers evaluate feasibility of using stem cell therapies on preterm infants to treat BPD

Researchers evaluate feasibility of using stem cell therapies on preterm infants to treat BPD

Incyte enters into clinical trial collaboration agreement with Merck to evaluate safety of IDO1 inhibitor

Incyte enters into clinical trial collaboration agreement with Merck to evaluate safety of IDO1 inhibitor

Pfizer and Merck join forces to explore therapeutic potential of anti-PD-1 therapy

Pfizer and Merck join forces to explore therapeutic potential of anti-PD-1 therapy

Findings raise hope for new oral anticoagulants to treat patients with atrial fibrillation

Findings raise hope for new oral anticoagulants to treat patients with atrial fibrillation

Bioengineer receives $1.4M grant to create nanoparticle system to shore up arterial walls

Bioengineer receives $1.4M grant to create nanoparticle system to shore up arterial walls

New drug treatment effective against chronic pain caused by nerve damage post shingles

New drug treatment effective against chronic pain caused by nerve damage post shingles

Psoriasis registry: an interview with Dr. Andrew D. Robertson, Chief Scientific and Medical Officer, National Psoriasis Foundation

Psoriasis registry: an interview with Dr. Andrew D. Robertson, Chief Scientific and Medical Officer, National Psoriasis Foundation

Furiex announces top-line results of Phase III clinical trials of eluxadoline in treatment of IBS-d

Furiex announces top-line results of Phase III clinical trials of eluxadoline in treatment of IBS-d

Pfizer’s palbociclib Phase 2 trial achieves primary endpoint in patients with advanced breast cancer

Pfizer’s palbociclib Phase 2 trial achieves primary endpoint in patients with advanced breast cancer

Innovation Center's methods under the microscope

Innovation Center's methods under the microscope

Researchers discover genetic function that helps "tumor suppressor" genes to prevent cancer

Researchers discover genetic function that helps "tumor suppressor" genes to prevent cancer

Incontinence prophylaxis shows potential in pelvic organ prolapse

Incontinence prophylaxis shows potential in pelvic organ prolapse

First Edition: February 3, 2014

First Edition: February 3, 2014

Ferrer executes two agreements to support clinical studies of Lorediplon in insomnia patients

Ferrer executes two agreements to support clinical studies of Lorediplon in insomnia patients

Mylan launches trastuzumab biosimilar for treatment of HER2-positive metastatic breast cancer

Mylan launches trastuzumab biosimilar for treatment of HER2-positive metastatic breast cancer

New study reveals way to combat drug-resistant tumors

New study reveals way to combat drug-resistant tumors

Vanda Pharmaceuticals announces FDA approval of HETLIOZ for Non-24 treatment

Vanda Pharmaceuticals announces FDA approval of HETLIOZ for Non-24 treatment

AbbVie's global sales reduce 1.8% to $5.111B in fourth quarter 2013

AbbVie's global sales reduce 1.8% to $5.111B in fourth quarter 2013

Aerie Pharmaceuticals announces dosing of first patients in PG324 Phase 2b study

Aerie Pharmaceuticals announces dosing of first patients in PG324 Phase 2b study

AVEO Oncology, Astellas Pharma decide to discontinue BATON breast cancer clinical trial

AVEO Oncology, Astellas Pharma decide to discontinue BATON breast cancer clinical trial

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.